AbCellera

Vancouver, Canada

AbCellera is an antibody discovery and development company that develops antibody therapeutics to improve patient outcomes.

$515.8M raised

May 2023

Grant

Top Investors

Founders FundEli LillyBill & Melinda Gates FoundationDCVC BioGovernment of Canada

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has AbCellera raised?

AbCellera has raised $515.8M in total funding. The most recent round was Grant. The last funding was announced in May 2023.

Who are AbCellera's investors?

AbCellera's investors include Founders Fund, Eli Lilly, Bill & Melinda Gates Foundation, DCVC Bio, Government of Canada.

Where is AbCellera headquartered?

AbCellera is headquartered in Vancouver, Canada.

What does AbCellera do?

AbCellera is an antibody discovery and development company that develops antibody therapeutics to improve patient outcomes.

What stage is AbCellera at?

AbCellera is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 24, 2023.

MLA

"AbCellera — Funding & Investors." VCBacked, May 24, 2023, https://www.vcbacked.co/company/abcellera. Accessed July 1, 2026.

APA

VCBacked. (2023). AbCellera — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/abcellera

Wikipedia (cite web)

{{cite web |title=AbCellera — Funding & Investors |url=https://www.vcbacked.co/company/abcellera |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 24, 2023.